Read more
12:27 · 22 January 2025

Abbott Laboratories published strong earnings and promising growth forecasts for 2025 🔔

-
-
Open account Download free app
Abbott Laboratories (ABT.US) loses 1.50% in pre-market trading after releasing Q4 2024 results. Abbott has concluded 2024 on a high note, showcasing robust performance and...

Log in or create a free account to keep reading

Analyses by award-winning experts

Create account  Log in

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Join over 2 Million investors from around the world